Comparison of intraperitoneal anti-adhesive polysaccharides derived from Phellinus mushrooms in a rat peritonitis

Jae-Sung Bae1, Kwang-Ho Jang, Hee-Kyung Jin

  • 1Department of Surgery, College of Veterinary Medicine, Kyungpook National University, Daegu 702-701, Republic of Korea.

Abstract

Insights

Polysaccharides from Phellinus gilvus and Phellinus linteus fungi significantly reduced adhesions and abscesses in a rat peritonitis model. The optimal concentration of 0.5% may modulate urokinase-type plasminogen activator and tumor necrosis factor-alpha activity.

Area of Science:

  • Biochemistry
  • Immunology
  • Pharmacology

Background:

  • Peritonitis is a serious intra-abdominal infection.
  • Adhesions and abscesses are common complications of peritonitis.
  • Fungal polysaccharides are known for their immunomodulatory properties.

Purpose of the Study:

  • To evaluate the efficacy of Phellinus gilvus (PG) and Phellinus linteus (PL) polysaccharides in reducing adhesions and abscesses.
  • To determine the optimal concentration of these fungal polysaccharides for therapeutic use.
  • To investigate the molecular mechanisms underlying their anti-inflammatory effects.

Main Methods:

  • Experimental peritonitis was induced in rats using the cecal ligation and puncture (CLP) model.
  • Rats were treated with varying concentrations of PG or PL polysaccharides, or hyaluronic acid.
  • Adhesion and abscess formation were assessed, and cecal tissue was analyzed using RT-PCR.

Main Results:

  • PG and PL polysaccharides significantly reduced adhesion formation at concentrations of 0.25% and 0.5%.
  • All treated groups showed a significant reduction in abscess incidence compared to the control group.
  • Polysaccharide treatment upregulated urokinase-type plasminogen activator (uPA) and increased expression of uPA receptor (uPAR) and tumor necrosis factor-alpha (TNF-alpha) mRNA.

Conclusions:

  • 0.5% PG and PL polysaccharides are optimal for preventing adhesions and abscesses in a rat peritonitis model.
  • These fungal polysaccharides may exert their effects by modulating uPA and TNF-alpha activity.
  • Fungal polysaccharides show potential as therapeutic agents for peritonitis complications.

Related Concept Videos